Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19217558 | 1.00 | ALDH1A1 (0.73) | ALDH1A1CYP3A4 | |
| SCHEMBL14198783 | 0.86 | ALDH1A1 (0.73) | ALDH1A1CYP3A4 | |
| SCHEMBL28910450 | 0.85 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL30393565 | 0.85 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL5610404 | 0.85 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL29932997 | 0.85 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL15846 | 0.85 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL2821152 | 0.85 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL6836764 | 0.85 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 | |
| SCHEMBL14679716 | 0.85 | ALDH1A1 (1.00) | ALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230210635-A1 | CURABLE COMPOSITION FOR USE IN A HIGH TEMPERATURE LITHOGRAPHY-BASED PHOTOPOLYMERIZATION PROCESS AND METHOD OF PRODUCING CROSSLINKED POLYMERS THEREFROM | ALIGN TECHNOLOGY INC (US) | 2023-07-06 | — | — | US | disclosed |
| US-11542362-B2 | Curable composition for use in a high temperature lithography-based photopolymerization process and method of producing crosslinked polymers therefrom | ALIGN TECHNOLOGY, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| EP-3158399-B1 | POLYURETHANE RESINS HAVING MULTIPLE MECHANISMS OF HARDENING FOR USE IN PRODUCING THREE-DIMENSIONAL OBJECTS | CARBON INC (US) | 2022-10-26 | — | — | EP | disclosed |
| EP-3157722-B1 | THREE-DIMENSIONAL OBJECTS PRODUCED FROM MATERIALS HAVING MULTIPLE MECHANISMS OF HARDENING | CARBON INC (US) | 2022-06-01 | — | — | EP | disclosed |
| EP-3158400-B1 | METHODS OF PRODUCING THREE-DIMENSIONAL OBJECTS FROM MATERIALS HAVING MULTIPLE MECHANISMS OF HARDENING | CARBON INC (US) | 2022-06-01 | — | — | EP | disclosed |
| US-11312084-B2 | Methods for producing helmet inserts with materials having multiple mechanisms of hardening | CARBON, INC. (US) | 2022-04-26 | — | — | US | disclosed |
| US-10954334-B2 | — | — | 2021-03-23 | — | — | US | disclosed |
| US-20210024775-A1 | METHODS FOR PRODUCING HELMET INSERTS WITH MATERIALS HAVING MULTIPLE MECHANISMS OF HARDENING | CARBON INC (US) | 2021-01-28 | — | — | US | disclosed |
| US-20200040130-A1 | CURABLE COMPOSITION FOR USE IN A HIGH TEMPERATURE LITHOGRAPHY-BASED PHOTOPOLYMERIZATION PROCESS AND METHOD OF PRODUCING CROSSLINKED POLYMERS THEREFROM | ALIGN TECHNOLOGY, INC. | 2020-02-06 | — | — | US | disclosed |
| EP-2603539-B1 | METHOD FOR PREPARING A POLYCARBAMIDE RESIN | ECOPOLIMERI S R L (IT) | 2019-01-02 | — | — | EP | disclosed |
| US-8944804-B2 | Nanostructured surfaces for biomedical/biomaterial applications and processes thereof | LIQUIDIA TECHNOLOGIES, INC. (US) | 2015-02-03 | — | — | US | disclosed |
| US-20150004113-A1 | SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH TERMINAL ORGANOFUNCTIONAL RADICALS COMPRISING UREA AND/OR CARBAMATE GROUPS AND AMINO ACID RADICALS | EVONIK DEGUSSA GMBH (DE) | 2015-01-01 | — | — | US | disclosed |
| US-20150004112-A1 | SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH ORGANOFUNCTIONAL RADICALS EACH HAVING AT LEAST TWO BIVALENT GROUPS SELECTED FROM UREA AND/OR CARBAMATE GROUPS AND AT LEAST ONE UV/VIS CHROMOPHORE AS RADICAL | EVONIK INDUSTRIES AG (DE) | 2015-01-01 | — | — | US | disclosed |
| US-8662878-B2 | Methods and materials for fabricating laminate nanomolds and nanoparticles therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2014-03-04 | — | — | US | disclosed |
| US-20130202729-A1 | Methods and Materials for Fabricating Laminate Nanomolds and Nanoparticles Therefrom | LIQUIDIA TECHNOLOGIES, INC. (US) | 2013-08-08 | — | — | US | disclosed |
| US-8444899-B2 | Methods and materials for fabricating microfluidic devices | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2013-05-21 | — | — | US | disclosed |
| US-20120256354-A1 | METHODS AND MATERIALS FOR FABRICATING MICROFLUIDIC DEVICES | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2012-10-11 | — | — | US | disclosed |
| US-20090250588-A1 | Nanostructured Surfaces for Biomedical/Biomaterial Applications and Processes Thereof | LIQUIDIA TECHNOLOGIES, INC. (US) | 2009-10-08 | — | — | US | disclosed |
| WO-2008143650-A2 | METHODS AND MATERIALS FOR FABRICATING LAMINATE NANOMOLDS AND NANOPARTICLES THEREFROM | LIQUIDIA TECHNOLOGIES, INC. (US) | 2008-11-27 | — | — | WO | disclosed |
| US-4028306-A | COATINGS | BAYER AKTIENGESELLSCHAFT (DT) | 1977-06-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150004112-A1 | SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH ORGANOFUNCTIONAL RADICALS EACH HAVING AT LEAST TWO BIVALENT GROUPS SELECTED FROM UREA AND/OR CARBAMATE GROUPS AND AT LEAST ONE UV/VIS CHROMOPHORE AS RADICAL | CCNI, UBE2I, CCNB1 | ALDH1A1 2209/4885CYP3A4 1031/4885 |
| US-20150004113-A1 | SILOXANE POLYMERS WITH A CENTRAL POLYSILOXANE POLYMER BLOCK WITH TERMINAL ORGANOFUNCTIONAL RADICALS COMPRISING UREA AND/OR CARBAMATE GROUPS AND AMINO ACID RADICALS | UBE2I, CCNI, IL4I1 | ALDH1A1 3526/4885CYP3A4 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.